Public Health On Call 726 - Substandard and Fake Drugs
Feb 28, 2024
Dr. Murray Lumpkin discusses the global issue of substandard and fake drugs, the risks they pose, and the challenges faced by regulatory systems. The importance of collaborative efforts to secure the pharmaceutical supply chain and investing in quality over price for better patient outcomes are highlighted.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Global Concerns: Substandard and Falsified Drugs
02:27 • 8min
Navigating the Global Regulatory Ecosystem for Medical Products
10:42 • 4min
Challenges of Ensuring Quality in Global Pharmaceutical Supply Chains
14:13 • 4min
Ensuring Quality in Healthcare Systems Through Regulatory Infrastructure
18:17 • 3min